These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3246395)

  • 41. The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece.
    Economidou J; Constantoulakis M; Augustaki O; Taylor PE; Zuckerman AJ; Baines PM; Bryceson MA
    Vox Sang; 1970; 19(3):401-3. PubMed ID: 4993791
    [No Abstract]   [Full Text] [Related]  

  • 42. [Hepatitis B virus infection in the absence of serological markers or with atypical serological patterns].
    Moreno García M
    Rev Clin Esp; 1997 Apr; 197(4):248-58. PubMed ID: 9254401
    [No Abstract]   [Full Text] [Related]  

  • 43. Correlation of serum anti-delta with intrahepatic HBV and HDV antigens in patients with chronic active hepatitis.
    Caporaso N; Di Sapio M; Del Vecchio-Blanco C; Coltorti M
    Prog Clin Biol Res; 1987; 234():137-44. PubMed ID: 3628372
    [No Abstract]   [Full Text] [Related]  

  • 44. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 45. [The significance of studying the HBe system in the prognosis of patients with acute and chronic viral hepatitis Be].
    Perisić-Savić M; Nastić-Mirić D
    Srp Arh Celok Lek; 1983; 111(9-10):1343-50. PubMed ID: 6681452
    [No Abstract]   [Full Text] [Related]  

  • 46. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors.
    Neriishi K; Akiba S; Amano T; Ogino T; Kodama K
    Radiat Res; 1995 Nov; 144(2):215-21. PubMed ID: 7480648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Delta agent infection in hemophilia].
    Miura T; Inagaki M
    Rinsho Byori; 1987 Sep; Spec No 73():74-8. PubMed ID: 3437535
    [No Abstract]   [Full Text] [Related]  

  • 49. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
    Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
    Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hbeag/Anti-hbe system and other markers for hepatitis b in a dialysis unit (author's transl)].
    Turci F; Iosa G; Cipolloni A; Cenciotti L
    Quad Sclavo Diagn; 1980 Dec; 16(4):349-55. PubMed ID: 7244108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand.
    Laosombat V; Pornpatkul M; Wongchanchailert M; Worachat K; Wiriyasatienku A
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):149-53. PubMed ID: 9322298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis B virus markers in blood donors in the west of Scotland.
    Barr A; Houston SR; MacVarish IP; Dow BC; Mitchell R; Crawford RJ
    Med Lab Sci; 1981 Oct; 38(4):405-7. PubMed ID: 7329226
    [No Abstract]   [Full Text] [Related]  

  • 53. Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.
    De Virgiliis S; Fiorelli G; Fargion S; Cornacchia G; Sanna G; Cossu P; Murgia V; Cao A
    J Clin Pathol; 1980 Oct; 33(10):949-53. PubMed ID: 7430360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients.
    Papaevangelou G; Frösner G; Economidou J; Parcha S; Roumeliotou A
    Br Med J; 1978 Mar; 1(6114):689-91. PubMed ID: 630296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serologic evidence of hepatitis A and B virus infections in thalassemia patients: a retrospective study.
    Stevens CE; Silbert JA; Miller DR; Dienstag JL; Purcell RH; Szmuness W
    Transfusion; 1978; 18(3):356-60. PubMed ID: 664004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B infection in multitransfused thalassaemics.
    George E; Ilina I; Yasmin AM; George R; Duraisamy G
    Med J Malaysia; 1988 Dec; 43(4):284-7. PubMed ID: 3241594
    [No Abstract]   [Full Text] [Related]  

  • 57. Disappearance after two years of HBsAg and HBsAb in multiply transfused thalassemic patients and in their relatives in Sardinia.
    Scalise G; Cuccuru G; Stangoni A; Mela G; Cutillo S; Dore A; Gioannini P
    Panminerva Med; 1979; 21(1):7-10. PubMed ID: 492747
    [No Abstract]   [Full Text] [Related]  

  • 58. [Frequency of finding the markers of hepatitis B virus infection in infants in the 1st year of life receiving a plasma transfusion].
    Sychev AV; Mikhaĭlov MI; Shakhgil'dian IV; Golosova TV; Vlasikhina EN
    Vopr Virusol; 1985; 30(5):553-8. PubMed ID: 4072158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-nuclear antibody positivity in multi-transfused thalassemia major.
    Agarwal MB; Viswanathan C; Gupte SS; Desai NG; Vasandani D; Bhave AA
    Indian Pediatr; 1992 May; 29(5):607-10. PubMed ID: 1500109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of haemotherapy in thalassaemias (20 years of Indian experience).
    Jolly JG; Agnihotri SK; Choudhury N; Gupta D
    J Indian Med Assoc; 1992 Jan; 90(1):7-9. PubMed ID: 1593146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.